SCHEMBL7225643

SCHEMBL7225643

COc1ccc2c(c1)nc([S+]([O-])Cc1ncc(C)c(OC)c1C)n2S(=O)(=O)c1cccc(S(=O)(=O)n2c([S+]([O-])Cc3ncc(C)c(OC)c3C)nc3ccc(OC)cc32)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 2/20 0.43
KMT2A Q03164 6/20 0.39
WDR5 P61964 3/20 0.39
ALDH1A1 P00352 3/20 0.39
HTT P42858 3/20 0.39
SMN1; SMN2 Q16637 3/20 0.39
BRS3 P32247 2/20 0.39
KDM4E B2RXH2 2/20 0.39
ATP1A1 P05023 2/20 0.39
ATP1B1 P05026 2/20 0.39
ATP1A3 P13637 2/20 0.39
ATP1B2 P14415 2/20 0.39
ATP4A P20648 2/20 0.39
ATP1A2 P50993 2/20 0.39
ATP4B P51164 2/20 0.39
ATP1B3 P54709 2/20 0.39
FXYD2 P54710 2/20 0.39
ATP1A4 Q13733 2/20 0.39
MEN1 O00255 2/20 0.39
MAPT P10636 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7231795 0.97 CYP2C9 (0.43) CYP2C9KMT2AWDR5ALDH1A1HTT
SCHEMBL7231172 0.97 CYP2C9 (0.45) CYP2C9KMT2AWDR5ALDH1A1HTT
SCHEMBL7012878 0.92 CYP2C9 (0.45) CYP2C9KMT2AWDR5ALDH1A1HTT
SCHEMBL7013702 0.92 CYP2C9 (0.43) CYP2C9KMT2AWDR5ALDH1A1HTT
SCHEMBL7009476 0.91 CYP2C9 (0.45) CYP2C9KMT2AWDR5ALDH1A1HTT
SCHEMBL7008250 0.91 CYP2C9 (0.47) CYP2C9KMT2AWDR5ALDH1A1HTT
SCHEMBL7009636 0.89 CYP2C9 (0.44) CYP2C9KMT2AWDR5ALDH1A1HTT
SCHEMBL7012965 0.89 CYP2C9 (0.46) CYP2C9KMT2AWDR5ALDH1A1HTT
SCHEMBL7008811 0.89 CYP2C9 (0.41) CYP2C9KMT2AWDR5ALDH1A1HTT
SCHEMBL5762257 0.89 CYP2C9 (0.41) CYP2C9KMT2AWDR5ALDH1A1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6559167-B1 Prodrugs of the pyridyl methyl sulfinyl benzimidazole type proton pump inhibitor drugs have a hydrolyzable arylsulfonyl or heteroarylsulfonyl group attached to the benzimidazole nitrogen. The prodrugs of the invention hydrolyze under REGENTS OF THE UNIVERSITY OF CALIFORNIA 2003-05-06 US claimed
US-6559167-B1 Prodrugs of the pyridyl methyl sulfinyl benzimidazole type proton pump inhibitor drugs have a hydrolyzable arylsulfonyl or heteroarylsulfonyl group attached to the benzimidazole nitrogen. The prodrugs of the invention hydrolyze under REGENTS OF THE UNIVERSITY OF CALIFORNIA 2003-05-06 US disclosed